Abstract
Purpose. The purpose of this study was to characterize the solubilization and precipitation characteristics of a range of poorly water-soluble drugs during the in vitro digestion of long-chain or medium-chain triglyceride (TG) lipid suspension formulations.
Methods. TG suspensions of model drugs (present at double their equilibrium solubilities in the respective lipid) were digested in vitro and the drug solubilization and precipitation pattern in the resulting digests analyzed.
Results. For griseofulvin, diazepam, and danazol, solubilization of the small mass of drug originally presented in the TG lipid was efficient with only a small proportion of the dose precipitating and being recovered in the pellet phase after digestion of the TG lipid. For the more lipophilic and lipid-soluble drugs (cinnarizine, halofantrine), in which higher drug loadings were possible, significant enhancement in drug solubilization in the postdigestion aqueous phase was not apparent compared with simple TG lipid solutions.
Conclusions. Suspensions of drugs, which are poorly soluble in water and TG lipid, may prove beneficial as the relatively high solubilizing capacity of the colloidal phases produced on TG digestion will likely exceed the mass of drug that could have been administered as a simple lipid solution. However, for more lipid-soluble drugs, suspension formulations may offer little benefit as sufficiently high drug loadings can otherwise be achieved with simple solution formulations that still provide for adequate solubilization after TG digestion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
references
T. R. Bates and J. A. Sequeira. Bioavailability of micronized griseofulvin from corn oil-in-water emulsion, aqueous suspension, and commercial tablet dosage forms in humans. J. Pharm. Sci. 64:793-797 (1975).
C. M. Ginsburg, G. H. McCracken, M. Petruska, and K. Olsen. Effect of feeding on bioavailability of griseofulvin in children. J. Pediatr. 102:309-311 (1983).
K. A. Milton, G. Edwards, S. A. Ward, M. L. E. Orme, and A. M. Breckenridge. Pharmacokinetics of halofantrine in man: effects of food and dose size. Br. J. Clin. Pharmacol. 28:71-77 (1989).
W. N. Charman, M. C. Rogge, A. W. Boddy, and B. M. Berger. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J. Clin. Pharmacol. 33:381-386 (1993).
A. J. Humberstone and W. N. Charman. Lipid based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Del. Rev. 25:103-128 (1997).
T. Gershanik and S. Benita. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 50:179-188 (2000).
C. W. Pouton. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and “self-microemulsifying” drug delivery systems. Eur. J. Pharm. Sci. 11:S93-S98 (2000).
A. J. Humberstone, C. J. H. Porter, and W. N. Charman. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine. J. Pharm. Sci. 85:525-529 (1996).
W. N. Charman, C. J. H. Porter, S. Mithani, and J. B. Dressman. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J. Pharm. Sci. 86:269-282 (1997).
K. J. MacGregor, J. K. Embleton, J. E. Lacy, A. P. Perry, L. J. Solomon, H. Seager, and C. W. Pouton. Influence of lipolysis on drug absorption from the gastro-intestinal tract. Adv. Drug Del. Rev. 25:33-46 (1997).
C. J. H. Porter and W. N. Charman. In vitro assessment of oral lipid based formulations. Adv. Drug Del. Rev. 50:S127-S147 (2001).
A. M. Kaukonen, B. J. Boyd, C. J. H. Porter, and W. N. Charman. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm. Res. 21:245-253 (2003).
S-M. Khoo, R. J. Prankerd, G. A. Edwards, C. J. H. Porter, and W. N. Charman. A physicochemical basis for the extensive Intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride after past prandial administration to dogs. J. Pharm. Sci. 91:647-659 (2002).
L. Sek, C. J. H. Porter, and W. N. Charman. Characterization and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. J. Pharm. Biomed. Anal. 25:651-661 (2001).
M. Armand, P. Borel, B. Pasquier, C. Dubois, M. Senft, M. Andre, J. Peyrot, J. Salducci, and D. Lairon. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am. J. Physiol. 271:G172-G183 (1996).
S. D. Ladas, P. E. T. Isaacs, G. M. Murphy, and G. E. Sladen. Comparison of the effects of medium and long chain triglyceride containing liquid meals on gall bladder and small intestinal function in normal man. Gut 25:405-411 (1984).
O. Hernell, J. E. Staggers, and M. C. Carey. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry 29:2041-2056 (1990).
L. Sek, C. J. H. Porter, A. M. Kaukonen, and W. N. Charman. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behavior of their lipolytic products. J. Pharm. Pharmacol. 54:29-41 (2002).
D. P. Cistola, J. A. Hamilton, D. Jackson, and D. M. Small. Ionization and phase behavior of fatty acids in water: application of the Gibbs phase rule. Biochemistry 27:1881-1888 (1988).
J. E. Staggers, O. Hernell, R. J. Stafford, and M. C. Carey. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry 29:2028-2040 (1990).
G. K. Kossena, B. J. Boyd, C. J. H. Porter, and W. N. Charman. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water soluble drugs. J. Pharm. Sci. 92:634-648 (2003).
E. A. Mueller, J. M. Kovarik, J. B. van Bree, J. Grevel, P. W. Lucker, and K. Kutz. Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation. Pharm. Res. 11:151-155 (1994).
B. J. Aungst. P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs. Adv. Drug Del. Rev. 39:105-116 (1999).
S-M. Khoo, A. J. Humberstone, C. J. H. Porter, G. A. Edwards, and W. N. Charman. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int. J. Pharm. 167:155-164 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaukonen, A.M., Boyd, B.J., Charman, W.N. et al. Drug Solubilization Behavior During in Vitro Digestion of Suspension Formulations of Poorly Water-Soluble Drugs in Triglyceride Lipids. Pharm Res 21, 254–260 (2004). https://doi.org/10.1023/B:PHAM.0000016283.87709.a9
Issue Date:
DOI: https://doi.org/10.1023/B:PHAM.0000016283.87709.a9